Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

IAC Inc a un objectif de cours consensuel de $57.26 basé sur les évaluations de 19 analystes. Le plus élevé est $112, publié par Credit Suisse le août 10, 2023. Le plus bas est $14, publié par Macquarie le novembre 14, 2024. Les 3 évaluations d’analystes les plus récentes ont été publiées par UBS, Barclays et Truist Securities le novembre 5, 2025, respectivement. Avec un objectif de cours moyen de $46.33 entre UBS, Barclays et Truist Securities, il existe une variation implicite de 40.62% upside pour IAC Inc selon ces dernières évaluations d’analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/05/2025 | 18.36% | UBS | $41 → $39 | Maintains | Neutral | |||
11/05/2025 | 45.68% | Barclays | $52 → $48 | Maintains | Overweight | |||
11/05/2025 | 57.81% | Truist Securities | $57 → $52 | Maintains | Buy | |||
11/05/2025 | 72.99% | Benchmark | $60 → $57 | Maintains | Buy | |||
11/03/2025 | 24.43% | Keybanc | $45 → $41 | Maintains | Overweight | |||
08/06/2025 | 18.36% | Piper Sandler | $44 → $39 | Maintains | Neutral | |||
08/06/2025 | 24.43% | UBS | $38 → $41 | Maintains | Neutral | |||
08/06/2025 | 82.09% | Benchmark | $63 → $60 | Maintains | Buy | |||
08/06/2025 | 36.57% | Keybanc | $49 → $45 | Maintains | Overweight | |||
08/06/2025 | 72.99% | Truist Securities | $61 → $57 | Maintains | Buy | |||
08/06/2025 | 66.92% | Oppenheimer | $60 → $55 | Maintains | Outperform | |||
06/10/2025 | 42.64% | JMP Securities | $64 → $47 | Maintains | Market Outperform | |||
05/07/2025 | 39.61% | Goldman Sachs | $60 → $46 | Maintains | Buy | |||
05/07/2025 | 15.33% | UBS | $54 → $38 | Maintains | Neutral | |||
05/07/2025 | 33.54% | Piper Sandler | $54 → $44 | Maintains | Neutral | |||
05/06/2025 | 57.81% | Barclays | $61 → $52 | Maintains | Overweight | |||
05/05/2025 | 48.71% | Keybanc | $64 → $49 | Maintains | Overweight | |||
04/25/2025 | 36.57% | Citigroup | $47.55 → $45 | Maintains | Buy | |||
04/22/2025 | 36.57% | JP Morgan | $60 → $45 | Maintains | Overweight | |||
03/21/2025 | 82.09% | JP Morgan | → $60 | Reinstates | → Overweight | |||
02/18/2025 | 94.23% | Keybanc | $60 → $64 | Maintains | Overweight | |||
02/13/2025 | 112.44% | Oppenheimer | $72 → $70 | Maintains | Outperform | |||
02/13/2025 | 203.49% | Benchmark | $105 → $100 | Maintains | Buy | |||
02/13/2025 | 94.23% | JMP Securities | $70 → $64 | Maintains | Market Outperform | |||
02/13/2025 | 63.88% | UBS | $55 → $54 | Maintains | Neutral | |||
02/13/2025 | 130.65% | Truist Securities | $80 → $76 | Maintains | Buy | |||
02/13/2025 | 85.13% | Barclays | $66 → $61 | Maintains | Overweight | |||
01/31/2025 | 76.02% | Citigroup | $56 → $58 | Maintains | Buy | |||
01/03/2025 | 69.95% | Citigroup | $60 → $56 | Maintains | Buy | |||
12/16/2024 | 112.44% | JMP Securities | $70 → $70 | Reiterates | Market Outperform → Market Outperform | |||
12/10/2024 | 63.88% | Piper Sandler | $68 → $54 | Downgrade | Overweight → Neutral | |||
11/20/2024 | 82.09% | Keybanc | $66 → $60 | Maintains | Overweight | |||
11/14/2024 | -57.51% | Macquarie | $14 → $14 | Maintains | Outperform | |||
11/13/2024 | 66.92% | UBS | $57 → $55 | Maintains | Neutral | |||
11/13/2024 | 133.69% | TD Cowen | $82 → $77 | Maintains | Buy | |||
11/13/2024 | 218.66% | Benchmark | $110 → $105 | Maintains | Buy | |||
11/13/2024 | 142.79% | Truist Securities | $88 → $80 | Maintains | Buy | |||
11/13/2024 | 100.3% | Barclays | $70 → $66 | Maintains | Overweight | |||
11/12/2024 | 233.84% | Benchmark | $110 → $110 | Reiterates | Buy → Buy | |||
10/28/2024 | 72.99% | UBS | $64 → $57 | Maintains | Neutral | |||
08/27/2024 | 233.84% | Benchmark | $110 → $110 | Reiterates | Buy → Buy | |||
08/16/2024 | 100.3% | Keybanc | $67 → $66 | Maintains | Overweight | |||
08/08/2024 | 100.3% | Citigroup | $70 → $66 | Maintains | Buy | |||
08/08/2024 | 112.44% | Barclays | $73 → $70 | Maintains | Overweight | |||
08/08/2024 | 233.84% | Benchmark | $110 → $110 | Reiterates | Buy → Buy | |||
08/08/2024 | 167.07% | Truist Securities | $87 → $88 | Maintains | Buy | |||
07/09/2024 | 136.72% | JMP Securities | → $78 | Initiates | → Market Outperform | |||
05/14/2024 | 154.93% | Wells Fargo | $82 → $84 | Maintains | Overweight | |||
05/13/2024 | 103.34% | Keybanc | $64 → $67 | Maintains | Overweight | |||
05/10/2024 | 164.04% | Truist Securities | $80 → $87 | Maintains | Buy | |||
05/09/2024 | 112.44% | Citigroup | $72 → $70 | Maintains | Buy | |||
05/09/2024 | 127.62% | Oppenheimer | $65 → $75 | Maintains | Outperform | |||
05/09/2024 | 121.55% | Barclays | $72 → $73 | Maintains | Overweight | |||
05/03/2024 | 94.23% | Keybanc | $72 → $64 | Maintains | Overweight | |||
02/16/2024 | 118.51% | Keybanc | $70 → $72 | Maintains | Overweight | |||
02/15/2024 | 94.23% | UBS | $60 → $64 | Maintains | Neutral | |||
02/15/2024 | 118.51% | Barclays | $62 → $72 | Maintains | Overweight | |||
02/15/2024 | 142.79% | Truist Securities | $77 → $80 | Maintains | Buy | |||
02/13/2024 | 112.44% | Keybanc | $68 → $70 | Maintains | Overweight | |||
11/27/2023 | 106.37% | Keybanc | $72 → $68 | Maintains | Overweight | |||
11/17/2023 | 63.88% | UBS | $66 → $54 | Maintains | Neutral | |||
11/09/2023 | 142.79% | Truist Securities | $84 → $80 | Maintains | Buy | |||
11/09/2023 | 91.2% | Piper Sandler | $74 → $63 | Maintains | Overweight | |||
11/09/2023 | 233.84% | Benchmark | $115 → $110 | Maintains | Buy | |||
11/07/2023 | 118.51% | Keybanc | $81 → $72 | Maintains | Overweight | |||
09/13/2023 | 154.93% | Truist Securities | → $84 | Reiterates | Buy → Buy | |||
08/28/2023 | 100.3% | UBS | $72 → $66 | Maintains | Neutral | |||
08/23/2023 | 145.83% | Keybanc | $82 → $81 | Maintains | Overweight | |||
08/21/2023 | 154.93% | Truist Securities | → $84 | Reiterates | Buy → Buy | |||
08/10/2023 | 142.79% | JP Morgan | $85 → $80 | Maintains | Overweight | |||
08/10/2023 | 112.44% | Oppenheimer | $75 → $70 | Maintains | Outperform | |||
08/10/2023 | 249.01% | Benchmark | $120 → $115 | Maintains | Buy | |||
08/10/2023 | 239.91% | Credit Suisse | $123 → $112 | Maintains | Outperform | |||
08/10/2023 | 109.41% | Citigroup | $71 → $69 | Maintains | Buy | |||
08/10/2023 | 127.62% | Barclays | $85 → $75 | Maintains | Overweight | |||
08/07/2023 | 148.86% | Keybanc | $72 → $82 | Maintains | Overweight | |||
05/30/2023 | 118.51% | Keybanc | $65 → $72 | Maintains | Overweight | |||
05/18/2023 | 142.79% | Jefferies | $70 → $80 | Maintains | Buy | |||
05/12/2023 | 115.48% | Citigroup | $64 → $71 | Maintains | Buy | |||
05/12/2023 | 139.76% | Wells Fargo | $70 → $79 | Maintains | Overweight | |||
05/11/2023 | 273.29% | Credit Suisse | $120 → $123 | Maintains | Outperform | |||
05/11/2023 | 167.07% | Truist Securities | $85 → $88 | Maintains | Buy | |||
05/11/2023 | 85.13% | UBS | $54 → $61 | Maintains | Neutral | |||
05/11/2023 | 127.62% | Oppenheimer | $70 → $75 | Maintains | Outperform | |||
05/11/2023 | 157.97% | Barclays | $75 → $85 | Maintains | Overweight | |||
05/03/2023 | 94.23% | Citigroup | $67 → $64 | Maintains | Buy | |||
02/15/2023 | 112.44% | Jefferies | $65 → $70 | Maintains | Buy | |||
02/15/2023 | 124.58% | Piper Sandler | $67 → $74 | Maintains | Overweight | |||
02/15/2023 | 63.88% | UBS | $46 → $54 | Upgrade | Sell → Neutral | |||
02/15/2023 | 124.58% | Goldman Sachs | $83 → $74 | Maintains | Buy | |||
02/15/2023 | 112.44% | Oppenheimer | → $70 | Reiterates | → Outperform | |||
02/15/2023 | 264.19% | Benchmark | $130 → $120 | Maintains | Buy | |||
02/15/2023 | 127.62% | Barclays | $70 → $75 | Maintains | Overweight | |||
02/15/2023 | 264.19% | Credit Suisse | $108 → $120 | Maintains | Outperform | |||
02/13/2023 | 103.34% | Citigroup | $60 → $67 | Maintains | Buy | |||
02/10/2023 | 294.54% | Benchmark | → $130 | Reiterates | → Buy | |||
01/19/2023 | 112.44% | Wells Fargo | $85 → $70 | Maintains | Overweight | |||
12/13/2022 | 82.09% | Citigroup | → $60 | Initiates | → Buy | |||
12/02/2022 | 39.61% | UBS | → $46 | Initiates | → Sell |
Le dernier objectif de prix pour IAC (NASDAQ:IAC) a été rapporté par UBS le novembre 5, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $39.00 s'attendant à ce que IAC se rise dans les 12 prochains mois (un possible changement de 18.36% upside). 32 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour IAC (NASDAQ:IAC) a été fournie par UBS, et IAC maintenu leur note neutral.
La dernière amélioration pour IAC Inc a eu lieu le février 15, 2023 lorsque UBS a augmenté leur objectif de prix à $54. UBS avait précédemment a sell pour IAC Inc.
La dernière réduction pour IAC Inc a eu lieu le décembre 10, 2024 lorsque Piper Sandler a changé leur objectif de prix de $68 à $54 pour IAC Inc.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de IAC, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour IAC a été déposée le novembre 5, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 5, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de IAC (IAC) était un maintenu avec un objectif de prix de $41.00 à $39.00. Le prix actuel de IAC (IAC) est de $32.95, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.